Victory Capital Management’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.2M Sell
501,857
-47,657
-9% -$2.59M 0.02% 739
2025
Q4
$25.4M Buy
549,514
+234,622
+75% +$10.5M 0.01% 797
2025
Q3
$11.3M Sell
314,892
-135,727
-30% -$4.5M 0.01% 1066
2025
Q2
$14.7M Buy
450,619
+229,800
+104% +$7.53M 0.01% 987
2025
Q1
$8.34M Sell
220,819
-82,737
-27% -$6.62M 0.01% 1118
2024
Q4
$24.8M Buy
303,556
+48,516
+19% +$4.82M 0.02% 761
2024
Q3
$29.1M Sell
255,040
-52,476
-17% -$4.73M 0.03% 685
2024
Q2
$23.2M Buy
307,516
+26,641
+9% +$1.81M 0.02% 751
2024
Q1
$19.2M Sell
280,875
-98,532
-26% -$6.82M 0.02% 834
2023
Q4
$23.8M Sell
379,407
-51,542
-12% -$2.68M 0.03% 712
2023
Q3
$22M Sell
430,949
-31,355
-7% -$1.55M 0.03% 715
2023
Q2
$23.1M Buy
462,304
+69,055
+18% +$3.27M 0.03% 720
2023
Q1
$14.7M Buy
393,249
+325,536
+481% +$13.8M 0.02% 891
2022
Q4
$3.25M Buy
67,713
+11,693
+21% +$459K ﹤0.01% 1309
2022
Q3
$1.34M Sell
56,020
-17,610
-24% -$446K ﹤0.01% 1603
2022
Q2
$1.6M Sell
73,630
-15,380
-17% -$356K ﹤0.01% 1541
2022
Q1
$2.15M Buy
+89,010
New +$1.94M ﹤0.01% 1473
2020
Q4
Sell
-5,102
Closed -$252K 2574
2020
Q3
$252K Buy
+5,102
New +$203K ﹤0.01% 2222

Other funds holding PCVX